Theralase Technologies Inc.

Theralase Technologies Inc.verified

TLTFF

Price:

$0.17

Market Cap:

$60.41M

Theralase Technologies Inc., founded in Toronto, Canada in 1994, is a clinical-stage pharmaceutical company focused on the development of innovative therapies and medical devices. The company's pharmaceutical division specializes in the research and development of photo dynamic compounds (PDCs) and their drug formulations. These advanced treatments are designed to combat cancer, bacterial infections, and viral diseases, with Theralase's operations spanning Canada, the United States, and other international regions. A significant drug candidate, TLD-1433, is presently in Phase II clinical trials for the treatment of Bacillus Calmette Guérin-unresponsive Carcinoma In-Situ non-muscle invasive b...[Read more]

Industry

Medical - Devices

IPO Date

2010-04-05

Stock Exchange

OTC

Ticker

TLTFF

The Enterprise Value as of June 2026 (TTM) for Theralase Technologies Inc. (TLTFF) is 59.84M

According to Theralase Technologies Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 59.84M. This represents a change of 12.43% compared to the average of 53.22M of the last 4 quarters.

Theralase Technologies Inc. (TLTFF) Historical Enterprise Value (quarterly & annually)

How has TLTFF Enterprise Value performed in the past?

The mean historical Enterprise Value of Theralase Technologies Inc. over the last ten years is 44.98M. The current 59.84M Enterprise Value has changed 13.20% with respect to the historical average. Over the past ten years (40 quarters), TLTFF's Enterprise Value was at its highest in in the March 2022 quarter at 91.44M. The Enterprise Value was at its lowest in in the September 2020 quarter at 19.91M.

Quarterly (TTM)
Annual

Average

44.98M

Median

40.33M

Minimum

25.38M

Maximum

73.97M

Theralase Technologies Inc. (TLTFF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theralase Technologies Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 138.42%

Maximum Annual Enterprise Value = 73.97M

Minimum Annual Increase = -39.03%

Minimum Annual Enterprise Value = 25.38M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202542.04M-33.94%
202463.64M59.36%
202339.94M-39.03%
202265.50M-11.45%
202173.97M138.42%
202031.02M-15.67%
201936.79M-9.66%
201840.72M32.35%
201730.77M21.24%
201625.38M-31.26%

Theralase Technologies Inc. (TLTFF) Average Enterprise Value

How has TLTFF Enterprise Value performed in the past?

The current Enterprise Value of Theralase Technologies Inc. (TLTFF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

48.54M

5-year avg

57.02M

10-year avg

44.98M

Theralase Technologies Inc. (TLTFF) Enterprise Value vs. Peers

How is TLTFF’s Enterprise Value compared to its peers?

Theralase Technologies Inc.’s Enterprise Value is greater than Vivos Inc. (29.69M), greater than Novacyt S.A. (17.69M), greater than Drug Free Solution, Inc. (76.39K), greater than Nova Eye Medical Limited (36.50M), less than Cynata Therapeutics Limited (60.71M), less than MedMira Inc. (62.90M), greater than Sernova Corp. (51.82M), greater than Bioqual, Inc. (51.28M), greater than PetVivo Holdings, Inc. (21.74M), greater than Medical Developments International Limited (30.40M),

Build a custom stock screener for Theralase Technologies Inc. (TLTFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralase Technologies Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theralase Technologies Inc. (TLTFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theralase Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Theralase Technologies Inc.'s Enterprise Value?

What is the highest Enterprise Value for Theralase Technologies Inc. (TLTFF)?

What is the 3-year average Enterprise Value for Theralase Technologies Inc. (TLTFF)?

What is the 5-year average Enterprise Value for Theralase Technologies Inc. (TLTFF)?

How does the current Enterprise Value for Theralase Technologies Inc. (TLTFF) compare to its historical average?